0001181431-14-028427.txt : 20140806 0001181431-14-028427.hdr.sgml : 20140806 20140806162617 ACCESSION NUMBER: 0001181431-14-028427 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140806 FILED AS OF DATE: 20140806 DATE AS OF CHANGE: 20140806 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Loxo Oncology, Inc. CENTRAL INDEX KEY: 0001581720 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462996673 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 LANDMARK SQUARE, SUITE 1122 CITY: STAMFORD STATE: CT ZIP: 06901 BUSINESS PHONE: 203-658-4749 MAIL ADDRESS: STREET 1: 1 LANDMARK SQUARE, SUITE 1122 CITY: STAMFORD STATE: CT ZIP: 06901 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DRANT RYAN D CENTRAL INDEX KEY: 0001302106 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36562 FILM NUMBER: 141020293 MAIL ADDRESS: STREET 1: 1119 ST PAUL STREET CITY: BALTIMORE STATE: MD ZIP: 21202 4 1 rrd413986.xml X0306 4 2014-08-06 0 0001581720 Loxo Oncology, Inc. LOXO 0001302106 DRANT RYAN D 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093 0 0 1 0 Common Stock 2014-08-06 4 C 0 1558651 A 1558651 I See Note 2 Common Stock 2014-08-06 4 P 0 230769 13 A 1789420 I See Note 2 Series B Convertible Preferred Stock 2014-08-06 4 C 0 1558651 D Common Stock 1558651 0 I See Note 2 In connection with the consummation of the Issuer's initial public offering on August 6, 2014, each share of Series B Convertible Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration. The Series B Convertible Preferred Stock had no expiration date. The Reporting Person is a director of NEA 14 GP, LTD, which is the sole general partner of NEA Partners 14, L.P. ("NEA Partners 14"). NEA Partners 14 is the sole general partner of New Enterprise Associates 14, L.P. ("NEA 14"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 14 shares in which the Reporting Person has no pecuniary interest. NEA 14 purchased these shares directly from the Issuer in a private placement. /s/ Sasha Keough, attorney-in-fact 2014-08-06